Study to Evaluate the Response Rate to Therapy With Docetaxel and Cisplatin in Unresectable Locally Advanced Squamous Cell Carcinoma of Head and Neck
Clinical trial NCT02061631 · COMPLETED
Trial details
- NCT number
- NCT02061631
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2015-07-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.